With HHS’s recent policy changes providing 503A compounding pharmacies with expanded opportunities in peptide compounding, now is an excellent time to explore new peptide formulations with SubOral™ SL HMW. SpecializedRx’s new proprietary, patent-pending anhydrous sublingual vehicle is designed to improve the solubility and sublingual penetration of oil- and water-soluble actives of both large and small molecular weight. If you’d like to evaluate SubOral™ SL HMW for your pharmacy, let me know, and I’d be happy to arrange a free sample.
Highlights:
- Anhydrous, water-soluble formulation enabling extended BUDs for a wide spectrum of prescriptions
- Employs functional ingredients for large and small molecular weight compounds to be administered sublingually
- Rapidly forms an occlusive hydrogel emulsion when exposed to saliva for improved bioavailability
- Formulated with a unique dual NADES and NPTS system that potentially delivers greater solubilization and penetration, enhancing drug absorption and leading to improved bioavailability
- Demonstrated great taste for prolonged sublingual absorption, leading to improved patient compliance and satisfaction
Resources:
Download SubOral™ SL HMW Technical Report 100078270
- Additional SubOral™ SL HMW Technical Reports in progress
Download SubOral™ SL HMW Technical Data Sheet
Shipping dates may be impacted by demand. If needed by a certain date, please contact a SpecializedRx representative to confirm availability. If you have any questions, need to place an order, would like to request a free sample, or for formula references, please email sales@specializedrx.com or call 888.512.1209!
